BR0204612C1 - hcv anti-nucleus monoclonal antibodies - Google Patents

hcv anti-nucleus monoclonal antibodies

Info

Publication number
BR0204612C1
BR0204612C1 BR0204612A BR0204612A BR0204612C1 BR 0204612 C1 BR0204612 C1 BR 0204612C1 BR 0204612 A BR0204612 A BR 0204612A BR 0204612 A BR0204612 A BR 0204612A BR 0204612 C1 BR0204612 C1 BR 0204612C1
Authority
BR
Brazil
Prior art keywords
monoclonal antibodies
nucleus
antibodies
hcv anti
hcv
Prior art date
Application number
BR0204612A
Other languages
Portuguese (pt)
Other versions
BR0204612A (en
Inventor
Chander Bahl
Original Assignee
Johnson & Johnson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson filed Critical Johnson & Johnson
Publication of BR0204612A publication Critical patent/BR0204612A/en
Publication of BR0204612C1 publication Critical patent/BR0204612C1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
    • C07K16/109—Hepatitis C virus; Hepatitis G virus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

"ANTICORPOS MONOCLONAIS ANTINúCLEO DE HCV". Anticorpos monoclonais que ligam-se especificamente ao antígeno de núcleo de HCV. São também fornecidas linhagens de célula de hibridoma que segregam estes anticorpos, métodos para preparo e emprego destes anticorpos, incluindo kits que incluem estes anticorpos."HCV ANTI-CORE MONOCLONAL ANTIBODIES". Monoclonal antibodies that specifically bind to HCV core antigen. Hybridoma cell lines secreting these antibodies, methods for preparing and employing these antibodies, including kits including these antibodies, are also provided.

BR0204612A 2001-11-05 2002-11-05 hcv anti-nucleus monoclonal antibodies BR0204612C1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33745301P 2001-11-05 2001-11-05

Publications (2)

Publication Number Publication Date
BR0204612A BR0204612A (en) 2003-09-16
BR0204612C1 true BR0204612C1 (en) 2008-04-15

Family

ID=27804960

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0204612A BR0204612C1 (en) 2001-11-05 2002-11-05 hcv anti-nucleus monoclonal antibodies

Country Status (1)

Country Link
BR (1) BR0204612C1 (en)

Also Published As

Publication number Publication date
BR0204612A (en) 2003-09-16

Similar Documents

Publication Publication Date Title
EP2186884A3 (en) HCV-anti-core monoclonal antibody
BR0111682A (en) Immunoassays for anti-hcv antibodies
DE69230146D1 (en) MONOCLONAL ANTIBODIES AGAINST PUTATIVE HCV-E2 / NS1 PROTEINS AND METHOD FOR THEIR USE
PT2305715T (en) Monoclonal antibody to osteoprotegerin binding protein
DE69939820D1 (en) INTERNALIZING ERBB2 ANTIBODIES
GB2383331A (en) Monoclonal antibody DS6 Tumor-associated antigen CA6 and methods of use thereof
DK1297017T3 (en) Compositions and Methods with Monoclonal and Polyclonal Antibodies Specific to T Cell Subpopulations
WO2001090358A3 (en) Mammalian receptor proteins; related reagents and methods
NO20051715L (en) HCV assay
ATE202117T1 (en) ANGIOTENSIN II RECEPTOR TYPE I SPECIFIC MONOCLONAL ANTIBODIES AND HYBRIDOMA
DE69224134D1 (en) Monoclonal antibodies to hepatitis C virus
DK0569537T3 (en) Monoclonal antibodies against putative HCV envelope regions and methods for their use
AU2003283240A8 (en) Antibody for isolating and/or identifying mesenchymal stem cells and method for isolating and/or identifying mesenchymal stem cells
BR0204612C1 (en) hcv anti-nucleus monoclonal antibodies
SE0002835D0 (en) Method and kit for production of monoclonal antibodies
DK0556320T3 (en) Hepatitis C virus monoclonal antibodies and methods for their use
DK0599913T3 (en) Monoclonal antibodies against putative hepatitis C virus NS5 proteins and methods of use of the same
AR037216A1 (en) HCV ANTINUCLEAR MONOCLONAL ANTIBODIES
DK1161522T3 (en) Method for Isolating CD8 + Cells and Related Hybridoma Cells, Antibodies and Polypeptides
ZA200200730B (en) Human monoclonal antibodies to prostate specific membrane antigen.

Legal Events

Date Code Title Description
B03B Publication of an application: anticipated publication

Free format text: REFERENTE A RPI 1706 DE 16/09/2003, QUANTO AO ITEM (30).

B06F Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
B06F Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
B07D Technical examination (opinion) related to article 229 of industrial property law
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 11A ANUIDADE.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2258 DE 15/04/2014.

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa)

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.